miR-1 induces endothelial dysfunction in rat pulmonary arteries

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Pulmonary Hypertension Research

Background:

• Endothelial dysfunction is a key factor in pulmonary arterial hypertension (PAH) pathogenesis.
• MicroRNAs (miRNAs) regulate gene expression and are implicated in various diseases.
• MicroRNA-1 (miR-1) is elevated in PAH, but its direct impact on endothelial function remains unclear.

Purpose of the Study:

• To investigate the specific effects of microRNA-1 (miR-1) on endothelial function in rat pulmonary arteries (PA).
• To determine the molecular mechanisms by which miR-1 influences endothelial cells in the context of PAH.

Main Methods:

• Pulmonary arteries from healthy and experimental PAH rats were analyzed using wire myography.
• Rat pulmonary artery smooth muscle cells (PASMC) were transfected with miR-1 or a control miRNA.
• Superoxide anion production was measured using dihydroethidium (DHE) fluorescence.
• Expression levels of potential miR-1 targets (SOD1, Cx43, CAV2, KLF4) were assessed via qRT-PCR and Western blot.

Main Results:

• miR-1 transfection led to reduced endothelium-dependent relaxation in pulmonary arteries.
• Increased superoxide anion (O2-) production was observed in PASMC treated with miR-1.
• miR-1 significantly decreased the expression of superoxide dismutase-1 (SOD1), connexin-43 (Cx43), caveolin 2 (CAV2), and Krüppel-like factor 4 (KLF4) in PASMC.

Conclusions:

• MicroRNA-1 induces endothelial dysfunction in rat pulmonary arteries.
• The observed effects of miR-1, including increased oxidative stress and reduced expression of target proteins, suggest a significant pathophysiological role in pulmonary arterial hypertension.